Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

ATP helps prevent skin damage from vandetanib by reducing stress.

A new compound shows promise as a topical treatment for hair loss.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Baricitinib is the most effective treatment for alopecia areata.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Nilotinib may cause gray hair to return to its original color.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ruxolitinib cream may help treat severe hair loss in children.

Baricitinib successfully treated severe hair loss.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.